Orchid Pharma Share Price Today | Stock Price & Orchid Pharma Share Screener

Track the current stock price of Orchid Pharma with an interactive chart. Analyse ORCHPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Orchid Pharma stock quote in one place.

The quote of ₹965.90 sits between the 52-week low of ₹482.45 and the 52-week high of ₹1,107.20, and the latest session moved -2.43% from the previous close.

Screen Orchid Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ORCHPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE191A01027.

Classification

Identifiers and Leadership

Screen ORCHPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,258, up from ₹2,077 in 2025.

Latest statistics put total assets at ₹2,258 and shareholder funds at ₹1,564, with a leverage ratio of 0.15.

Screen Orchid Pharma income statement and profit fundamentals. Analyze ORCHPHARMA quarterly results. Orchid Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹306 and net profit was ₹3, equal to earnings per unit of ₹0.54, at an operating margin of 5%.

In that period expenses were ₹290, interest cost ₹2 and tax ₹-1. The next period listed, 2026-Mar, shows revenue of ₹376 and net profit of ₹26.

Screen ORCHPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹126, and net cash flow was an outflow of ₹14.

Over the same period, investing activities used ₹277 and financing activities provided ₹137.

See Orchid Pharma shareholding pattern with promoter, FII, and DII holdings. Check Orchid Pharma promoter holding and ownership changes for ORCHPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 69.84%, foreign institutions 0.87%, domestic institutions 20.25% and the public 6.58%, spread across 35,118 shareholders.

The shareholder count was 35,118 in 2026-Mar, compared with 33,433 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Orchid Pharma. Orchid Pharma dividend yield can be compared with peers and other stocks in the market.

See which indices include Orchid Pharma stock. Check ORCHPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Orchid Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Orchid Pharma stock events that may affect ORCHPHARMA share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Merger - Demerger dated July 23, 2026.

Screen ORCHPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen ORCHPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated October 1, 2026 and September 30, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.